Clinical Drug Development

Queen Mary University of London

Postgraduate PgDip Full-time 9 Months Pharmacy, pharmacology, and toxicology

Clinical Drug Development PgDip is a postgraduate degree at Queen Mary University of London, based in Islington, taught full-time over 9 months.

About this course

The MSc in Clinical Drug Development provides students with a multidisciplinary perspective to facilitate their skills. The programme is designed for individuals who need an understanding of drug development process and provides a detailed picture of the complex and highly interrelated activities required for the development cycle for drugs and biologics, from the process of discovery to successful commercialisation.

- This programme provides students with the edge that the pharmaceutical industry requires.

- It empowers the professionals working within the field with the skills and understanding required for fast progression within the industry and contract research organisations (CROs).

Study Options

This course is available in 6 study options:

Part-time

Duration: 21 Months

Qualification: PgDip

Location: Islington

Full-time Shown above

Duration: 9 Months

Qualification: PgDip

Location: Islington

Part-time

Duration: 4 Years

Qualification: PgDip

Location: Islington

Part-time

Duration: 2 Years

Qualification: MSc

Location: Islington

Full-time Shown above

Duration: 1 Year

Qualification: MSc

Location: Islington

Part-time

Duration: 4 Years

Qualification: MSc

Location: Islington

Career Prospects

Graduates from this course typically go into the following occupations. Click through for salaries, employment rates and other UK degrees that lead there:

Related Courses

Course Details

Qualification
Postgraduate Diploma - PgDip
Study Mode
Full-time
Duration
9 Months
Start Date
2025

2025-entry data — 2026 offers may differ

Academic Year
2025
Campus / Location
Islington
Scheme
Postgraduate
Subjects
Pharmacy, pharmacology, and toxicology